ClinicalTrials.gov record
Not yet recruiting Phase 3 Interventional

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

ClinicalTrials.gov ID: NCT07509307

Public ClinicalTrials.gov record NCT07509307. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety of NNC0487-0111 s.c. Once-weekly in Participants With Overweight or Obesity, and Knee Osteoarthritis (AMAZE 6)

Study identification

NCT ID
NCT07509307
Recruitment status
Not yet recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
400 participants

Conditions and interventions

Interventions

  • NNC0487-0111 Drug
  • Placebo (matched to NNC0487-0111) Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 12, 2026
Primary completion
Jun 18, 2028
Completion
Jul 16, 2028
Last update posted
Apr 2, 2026

2026 – 2028

United States locations

U.S. sites
19
U.S. states
13
U.S. cities
17
Facility City State ZIP Site status
Neighborhood Healthcare Escondido California 92025
First Valley Medical Group Lancaster California 93534
Desert Oasis Healthcare Palm Springs California 92262
Chase Medical Research LLC Waterbury Connecticut 06708
Westside Center For Clinical Research Jacksonville Florida 32205
CNS Healthcare Jacksonville Florida 32256
Advanced Res for Health Improve Naples Florida 34102
Clinical Investigation Spec Gurnee Gurnee Illinois 60031
Evanston Premier Hlthcr Res Skokie Illinois 60077
Monroe Biomedical Research, LLC Louisville Kentucky 40213
Arcturus Healthcare, PLC. Troy Michigan 48098-6368
Clinvest Research Springfield Missouri 65807
NYU Langone Health New York New York 10016
Hospital For Special Surgery New York New York 10021
Piedmont Healthcare/Research Statesville North Carolina 28625
Northwest Research Center Portland Oregon 97202
Mercy Family Clinic Dallas Texas 75208
Health Res of Hampton Roads Newport News Virginia 23606
Northwest Clinical Research Center Bellevue Washington 98007

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 59 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07509307, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 2, 2026 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07509307 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →